149 related articles for article (PubMed ID: 10770434)
1. Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas.
Schaerer L; Schmid MH; Mueller B; Dummer RG; Burg G; Kempf W
Am J Dermatopathol; 2000 Apr; 22(2):140-3. PubMed ID: 10770434
[TBL] [Abstract][Full Text] [Related]
2. Increased angiogenesis in cutaneous T-cell lymphomas.
Mazur G; Woźniak Z; Wróbel T; Maj J; Kuliczkowski K
Pathol Oncol Res; 2004; 10(1):34-6. PubMed ID: 15029259
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas.
Cerroni L; Kerl H
Semin Cutan Med Surg; 1999 Mar; 18(1):64-70. PubMed ID: 10188844
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders.
Kamarashev J; Schaerer L; Burg G; Schmid MH; Müller B; Kempf W
J Cutan Pathol; 2001 Oct; 28(9):448-52. PubMed ID: 11553310
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
Kerl H; Fink-Puches R; Cerroni L
Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
[TBL] [Abstract][Full Text] [Related]
6. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
Bergman R
Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
[TBL] [Abstract][Full Text] [Related]
7. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis.
Teichert M; Stumpf C; Booken N; Wobser M; Nashan D; Hallermann C; Mogler C; Müller CS; Becker JC; Moritz RK; Andrulis M; Nicolay JP; Goerdt S; Thomas M; Klemke CD; Augustin HG; Felcht M
Exp Dermatol; 2015 Jun; 24(6):424-9. PubMed ID: 25776770
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma.
Wobser M; Siedel C; Kneitz H; Bröcker EB; Goebeler M; Houben R; Geissinger E
Acta Derm Venereol; 2013 Nov; 93(6):656-62. PubMed ID: 23624620
[TBL] [Abstract][Full Text] [Related]
9. Tumour-type-specific capillary endothelial cell stainability in malignant B-cell lymphomas using antibodies against CD31, CD34 and Factor VIII.
Norrby K; Ridell B
APMIS; 2003 Apr; 111(4):483-9. PubMed ID: 12780523
[TBL] [Abstract][Full Text] [Related]
10. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
Saji S; Toi M; Tominaga T
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects.
Rijlaarsdam U; Bakels V; van Oostveen JW; Gordijn RJ; Geerts ML; Meijer CJ; Willemze R
J Invest Dermatol; 1992 Dec; 99(6):749-54. PubMed ID: 1469288
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas.
Bairey O; Zimra Y; Kaganovsky E; Shaklai M; Okon E; Rabizadeh E
Med Oncol; 2000 Nov; 17(4):314-8. PubMed ID: 11114711
[TBL] [Abstract][Full Text] [Related]
13. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
14. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
15. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of primary and secondary cutaneous B-cell lymphoma by Southern blot analysis.
Sepp N; Weyer K; Haun M; Zelger B; Thaler J; Faber V; Fritsch P; Grünewald K
Am J Clin Pathol; 1996 Dec; 106(6):749-57. PubMed ID: 8980350
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
Cerroni L; Goteri G
Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
Guo J; Higashi K; Ueda Y; Oguchi M; Takegami T; Toga H; Sakuma T; Yokota H; Katsuda S; Tonami H; Yamamoto I
J Nucl Med; 2006 Mar; 47(3):419-25. PubMed ID: 16513610
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance related proteins in primary cutaneous lymphomas.
van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
[TBL] [Abstract][Full Text] [Related]
20. Role of gelatinases (MMP-2 and MMP-9), TIMP-1, vascular endothelial growth factor (VEGF), and microvessel density on the clinicopathological behavior of childhood non-Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pediatr Hematol Oncol; 2008; 25(1):55-66. PubMed ID: 18231955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
